article thumbnail

Integrating Digital Marketing in Pharmaceutical Industry: Unlocking New Opportunities for Patient Outreach and Engagement

Pharma Marketing Network

From search engine optimization (SEO) and social media marketing to email campaigns and targeted online advertisements, the digital space offers a wealth of opportunities for pharmaceutical companies to reach and influence their target audiences. Pharmaceutical Digital Marketing: Best Practices and Case Studies. 2019, March 21).

article thumbnail

Germany’s digital health changes will boost digital therapeutics in Europe

pharmaphorum

Germany is spearheading these advances, particularly with its 2019 changes on national digital health reimbursement. The last 12 months have shone a spotlight on digital transformation in Europe’s healthcare systems, with all the signs pointing to digital therapeutics (DTx) moving ever more into the healthcare mainstream.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How automatization keeps drug safety in war-torn Ukraine

pharmaphorum

Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a wide-scale war in Ukraine. Russia’s full-scale invasion of Ukraine has already affected the global pharmaceutical industry a lot. This platform made work easier for many pharmaceutical companies.

article thumbnail

Pfizer: Pharma needs a business strategy for a digital world

pharmaphorum

In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy. Digital fluency and change.

article thumbnail

Governments and pharma relationships and implications for antimicrobial resistance

Pharmaceutical Technology

million direct deaths in 2019 and an additional 4.95 A 2017 article in Health Policy estimates that the cost of developing an antibiotic is around $1.5bn, while according to a 2020 article in Nature, the average revenue generated from an antibiotic’s sale is about $46m a year.

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. million in 2019, and are estimated to increase to 5.7

article thumbnail

Pharma within planetary boundaries

European Pharmaceutical Review

The ERA therefore needs teeth – which does not mean it should be a barrier to the authorisation of new medicines – but it should require pharmaceutical companies to minimise harmful effects on the environment, which indirectly also harm our health. cited 23Apr]. Available from: [link]. Steenmeijer M, et al. Lancet Planetary Health.